NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/16/2024
Back to search
Official data from USPTO
APTOGENIX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
APTOGENIX
ST13
US500000097733640Class
5, 42
Filing
97733640
Registration
7445906
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
15
Latest update
07/16/2024
Classification
Registered
Trademark type
Word
Nice classes
5, 42
Filing date
12/28/2022
Registration date
07/16/2024
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/16/2024
Last transaction
07/16/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
99
Owner location
SINGAPORE, SG
Examiner
SMITH, CYNTHIA
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
APTOGENIX PTE. LTD.
Representatives
Zhuoyi Ma
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Dietary supplements; Dietary supplements with a cosmetic effect; Nutraceuticals for use as a dietary supplement; Pharmaceutical preparations for the central nervous system; Pharmaceutical preparations for the prevention of hypertensionhigh sugar levelhigh cholesteroldiabetescardiovascular diseasesinflammatory diseasesmuscle achesstressfatfrailtyfatiguehepatic lipid accumulation and hepatic damagecardio protection from toxic drugs
Class 42
Biological research; Biomedical research services; Development of pharmaceutical preparations and medicines; Medical research; Pharmaceutical research services; Providing medical and scientific research information in the field of clinical trials; Scientific laboratory services; Scientific research
Publications
History of USPTO decisions and trademark events.
15 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
07/16/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/30/2024
PUBO
PUBLISHED FOR OPPOSITION
04/30/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/10/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/26/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/26/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/26/2024
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
11/21/2023
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
09/26/2023
GNSL
LETTER OF SUSPENSION E-MAILED
09/26/2023
CNSL
SUSPENSION LETTER WRITTEN
09/26/2023
DOCK
ASSIGNED TO EXAMINER
09/26/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/23/2023
NWAP
NEW APPLICATION ENTERED
12/31/2022
Continuous trademark protection
Get notified about every new filing that threatens APTOGENIX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.